期刊
GASTROENTEROLOGIA Y HEPATOLOGIA
卷 45, 期 9, 页码 724-734出版社
ELSEVIER ESPANA SLU
DOI: 10.1016/j.gastrohep.2022.02.005
关键词
MAFLD; MASH; Steatohepatitis; Fibrosis; Hepatocellular carcinoma
This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, organized by the Spanish Association for the Study of the Liver (AEEH), provided updates on recent advances in basic and translational hepatology, focusing on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis, and end-stage hepatocellular carcinoma (HCC).
This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC). (C) 2022 The Authors. Published by Elsevier Espana, S.L.U.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据